In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era.

Michael built content and delivery organizations of over 1,000 people — and he has some of the most direct takes on where pharma transformation is stalling.

Key takeaways:

• Modular content served its purpose as a scalability crutch — but well-trained AI models will eventually make it obsolete
• MLR is a bottleneck not just because of technology, but because of trust — local approvers carry legal liability and need confidence in what they sign off
• AI systems must b ...